c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling.
about
Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage responseIdentification of cytotoxic drugs that selectively target tumor cells with MYC overexpressionRNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.Myc is required for activation of the ATM-dependent checkpoints in response to DNA damagec-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.Targeting of the MYCN protein with small molecule c-MYC inhibitorsFar upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.Bioelectronome. Integrated approach to receptor chemistry, radicals, electrochemistry, cell signaling, and physiological effects based on electron transfer.PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.High-dose etoposide in allogeneic stem cell transplantation.Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.Cytotoxicity and antiangiogenic activity of grandisin.Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression.Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
P2860
Q28239216-BEFDB13A-975C-4209-9894-185A195B7549Q28478132-A509FA18-6F57-4AD0-8D4F-25C233965A80Q33398834-9111B2D1-4C0D-4108-81FD-C4C96E23A562Q33527429-BA72EA3D-3F90-45A7-98E3-8DB9FB9FA121Q33821504-9EDACFD7-0951-4B87-B12A-D4573FC37F39Q35071356-23241E53-274C-42D0-A575-3F329625588EQ35173570-539844F4-0FBE-44F0-8CCB-45EAEC835915Q36246412-D9C59C09-9056-408C-B51F-167BCCC8AE8BQ36948324-48D5D8C4-1D33-44F7-B643-24A713E251DAQ37038041-A964D819-ED6D-41E3-BAAE-8CC159D88733Q38051016-43F84192-C815-4C53-8CD9-3D8947095845Q38088759-C0096981-9164-426B-AE58-247190D2671FQ38965179-1BF0E96D-2B5B-495E-B0A2-48B4877994B5Q45180255-E8F905A0-A353-461E-8FA7-D843844F5321Q50449106-57920AD2-D6FF-4131-838D-7A36548A3ADAQ53472176-6675304B-207D-48AC-8B70-0805F576CDF6Q54977126-3C24B696-99B5-4B88-9900-6CFA2305BA52
P2860
c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
c-Myc-dependent etoposide-indu ...... pases, and PKCdelta signaling.
@en
type
label
c-Myc-dependent etoposide-indu ...... pases, and PKCdelta signaling.
@en
prefLabel
c-Myc-dependent etoposide-indu ...... pases, and PKCdelta signaling.
@en
P2093
P356
P1476
c-Myc-dependent etoposide-indu ...... pases, and PKCdelta signaling.
@en
P2093
Ami Albihn
Jakob Lovén
Johan Ohlsson
Lyda M Osorio
Marie Henriksson
P304
P356
10.1002/JCB.20816
P577
2006-08-01T00:00:00Z